The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Preclinical CRO Market Research Report 2025

Global Preclinical CRO Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1415068

No of Pages : 88

Ask Your Query

Synopsis

A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.

The global Preclinical CRO market was valued at US$ 13020 million in 2023 and is anticipated to reach US$ 23370 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.

Global core preclinical CRO players include Charles River, Wuxi AppTec, Labcorp and Eurofins Scientific etc. The top 5 companies hold a share about 50%. North America is the largest market, with a share about 45%, followed by Asia Pacific and Europe with the share about 32% and 15%. In terms of product, bioanalysis and DMPK studies is the largest segment, with a share about 45%, followed by toxicology testing, with a share about 20%. And in terms of application, the largest application is pharmaceutical companies, with a share about 80%, followed by medical device companies.

This report aims to provide a comprehensive presentation of the global market for Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical CRO.

Report Scope

The Preclinical CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Charles River
  • Wuxi AppTec
  • Labcorp
  • Eurofins Scientific
  • PPD
  • ICON Plc
  • Pharmaron
  • Inotiv
  • ChemPartner
  • JOINN Lab
  • EVOTEC
  • Medicilon
  • Crown Bioscience
  • Champion Oncology

Segment by Type

  • Bioanalysis and DMPK Studies
  • Toxicology Testing
  • Safety Pharmacology
  • Others

Segment by Application

  • Pharmaceutical Companies
  • Medical Device Companies
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Safety Pharmacology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Preclinical CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical CRO Market Perspective (2019-2030)
2.2 Preclinical CRO Growth Trends by Region
2.2.1 Global Preclinical CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical CRO Historic Market Size by Region (2019-2024)
2.2.3 Preclinical CRO Forecasted Market Size by Region (2025-2030)
2.3 Preclinical CRO Market Dynamics
2.3.1 Preclinical CRO Industry Trends
2.3.2 Preclinical CRO Market Drivers
2.3.3 Preclinical CRO Market Challenges
2.3.4 Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical CRO Players by Revenue
3.1.1 Global Top Preclinical CRO Players by Revenue (2019-2024)
3.1.2 Global Preclinical CRO Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical CRO Revenue
3.4 Global Preclinical CRO Market Concentration Ratio
3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2023
3.5 Preclinical CRO Key Players Head office and Area Served
3.6 Key Players Preclinical CRO Product Solution and Service
3.7 Date of Enter into Preclinical CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Breakdown Data by Type
4.1 Global Preclinical CRO Historic Market Size by Type (2019-2024)
4.2 Global Preclinical CRO Forecasted Market Size by Type (2025-2030)
5 Preclinical CRO Breakdown Data by Application
5.1 Global Preclinical CRO Historic Market Size by Application (2019-2024)
5.2 Global Preclinical CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical CRO Market Size (2019-2030)
6.2 North America Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical CRO Market Size by Country (2019-2024)
6.4 North America Preclinical CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical CRO Market Size (2019-2030)
7.2 Europe Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical CRO Market Size by Country (2019-2024)
7.4 Europe Preclinical CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Market Size (2019-2030)
8.2 Asia-Pacific Preclinical CRO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical CRO Market Size (2019-2030)
9.2 Latin America Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical CRO Market Size by Country (2019-2024)
9.4 Latin America Preclinical CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Market Size (2019-2030)
10.2 Middle East & Africa Preclinical CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Preclinical CRO Introduction
11.1.4 Charles River Revenue in Preclinical CRO Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Detail
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Preclinical CRO Business (2019-2024)
11.2.5 Wuxi AppTec Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Preclinical CRO Business (2019-2024)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical CRO Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD
11.5.1 PPD Company Detail
11.5.2 PPD Business Overview
11.5.3 PPD Preclinical CRO Introduction
11.5.4 PPD Revenue in Preclinical CRO Business (2019-2024)
11.5.5 PPD Recent Development
11.6 ICON Plc
11.6.1 ICON Plc Company Detail
11.6.2 ICON Plc Business Overview
11.6.3 ICON Plc Preclinical CRO Introduction
11.6.4 ICON Plc Revenue in Preclinical CRO Business (2019-2024)
11.6.5 ICON Plc Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Detail
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Preclinical CRO Business (2019-2024)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Detail
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Preclinical CRO Business (2019-2024)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Detail
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Preclinical CRO Business (2019-2024)
11.9.5 ChemPartner Recent Development
11.10 JOINN Lab
11.10.1 JOINN Lab Company Detail
11.10.2 JOINN Lab Business Overview
11.10.3 JOINN Lab Preclinical CRO Introduction
11.10.4 JOINN Lab Revenue in Preclinical CRO Business (2019-2024)
11.10.5 JOINN Lab Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Detail
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Preclinical CRO Business (2019-2024)
11.11.5 EVOTEC Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Detail
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Preclinical CRO Business (2019-2024)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Detail
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Preclinical CRO Business (2019-2024)
11.13.5 Crown Bioscience Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Detail
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Preclinical CRO Business (2019-2024)
11.14.5 Champion Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock